(Q51017538)

27 March 2018

title

Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel. (English)

1 reference

27 March 2018

main subject

acute coronary syndrome

1 reference

2

1 reference

27 March 2018

Gilles Montalescot

11

Gilles Montalescot

1 reference

27 March 2018

4

Dariusz Dudek

1 reference

27 March 2018

Petr Widimský

1

Petr Widimsky

1 reference

27 March 2018

ACCOAST Investigators

12

ACCOAST Investigators

1 reference

27 March 2018

Jean-Francois Tanguay

6

Jean-Francois Tanguay

1 reference

27 March 2018

LeRoy LeNarz

9

LeRoy LeNarz

1 reference

27 March 2018

author name string

Leonardo Bolognese

3

1 reference

27 March 2018

Christian Hamm

5

1 reference

27 March 2018

Jurrien Ten Berg

7

1 reference

27 March 2018

Eileen Brown

8

1 reference

27 March 2018

Debra L Miller

10

1 reference

27 March 2018

language of work or name

English

0 references

publication date

9 June 2015

1 reference

27 March 2018

published in

Heart

1 reference

27 March 2018

volume

101

1 reference

27 March 2018

issue

15

1 reference

27 March 2018

page(s)

1219-1224

1 reference

27 March 2018

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

cites work

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Women, bleeding, and coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (T

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Is it possible to separate ischemic and bleeding risk in patients with non-ST segment elevation acute coronary syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

2013 ESC guidelines on the management of stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

Comparison of ischemic and bleeding risk scores in non-ST elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2015-307686

10.1136/HEARTJNL-2015-307686

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018